Charles Alpren and Amanda Burrage are with the Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Philip J. Peters, Sheryl B. Lyss, William M. Switzer, Ashley Murray, Christine Agnew-Brune, Erica L. Dawson, Nivedha Panneer, Paul McClung, Ellsworth M. Campbell, Sharoda Dasgupta, Kischa Hampton, William Adih, Susie P. Danner, Hongwei Jia, and Kate Buchacz are with the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), CDC. Betsey John, Kevin Cranston, H. Dawn Fukuda, Kathleen Roosevelt, R. Monina Klevens, Janice Bryant, Tracy Stiles, Courtney Breen, Liisa M. Randall, Shauna Onofrey, Katherine K. Hsu, Barry Callis, Linda R. Goldman, Matthew Tumpney, Catherine Brown, and Alfred DeMaria Jr are with the Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Boston, MA. Danae Bixler is with the Division of Viral Hepatitis, NCHHSTP, CDC. Jenifer Leaf Jaeger is with the Infectious Disease Bureau, Boston Public Health Commission, Boston. Amy Board is with the Oak Ridge Institute of Science and Education, Oak Ridge, TN.
Am J Public Health. 2020 Jan;110(1):37-44. doi: 10.2105/AJPH.2019.305366. Epub 2019 Nov 14.
To describe and control an outbreak of HIV infection among people who inject drugs (PWID). The investigation included people diagnosed with HIV infection during 2015 to 2018 linked to 2 cities in northeastern Massachusetts epidemiologically or through molecular analysis. Field activities included qualitative interviews regarding service availability and HIV risk behaviors. We identified 129 people meeting the case definition; 116 (90%) reported injection drug use. Molecular surveillance added 36 cases to the outbreak not otherwise linked. The 2 largest molecular groups contained 56 and 23 cases. Most interviewed PWID were homeless. Control measures, including enhanced field epidemiology, syringe services programming, and community outreach, resulted in a significant decline in new HIV diagnoses. We illustrate difficulties with identification and characterization of an outbreak of HIV infection among a population of PWID and the value of an intensive response. Responding to and preventing outbreaks requires ongoing surveillance, with timely detection of increases in HIV diagnoses, community partnerships, and coordinated services, all critical to achieving the goal of the national Ending the HIV Epidemic initiative.
描述和控制注射吸毒者(PWID)中 HIV 感染的爆发。调查包括在 2015 年至 2018 年期间与马萨诸塞州东北部的 2 个城市在流行病学上或通过分子分析相关联的 HIV 感染确诊病例。现场活动包括有关服务可用性和 HIV 风险行为的定性访谈。我们确定了 129 名符合病例定义的人;116 人(90%)报告了注射吸毒。分子监测增加了 36 例未通过其他方式联系的暴发病例。两个最大的分子群体包含 56 例和 23 例。大多数接受采访的 PWID 都是无家可归者。控制措施,包括加强现场流行病学、注射器服务规划和社区外展,导致新的 HIV 诊断病例显著减少。我们说明了在 PWID 人群中识别和描述 HIV 感染暴发的困难,以及强化应对的价值。应对和预防暴发需要持续监测,及时发现 HIV 诊断增加、社区伙伴关系和协调服务,这对于实现国家终结艾滋病流行倡议的目标至关重要。